This inventor holds 1 USPTO granted patent. Top assignee: Boehringer Ingelheim Pharma Gmbh & Co Kg. Active years: 2005.
Company Filing History:
Years Active: 2005
Title: The Innovations of Kandace Matzek in Veterinary Medicine
Introduction
Kandace Matzek is an accomplished inventor based in Ingelheim, Germany. She has made significant contributions to the field of veterinary medicine, particularly in the treatment of respiratory diseases in companion and domesticated animals. Her innovative approach has led to the development of a unique pharmaceutical composition that utilizes LTB4 antagonists.
Latest Patents
Kandace Matzek holds a patent for the "Use of LTB4 antagonists in veterinary medicine." This invention focuses on the application of LTB4 antagonists for preparing a pharmaceutical composition aimed at treating or preventing respiratory diseases in animals. This patent highlights her commitment to improving animal health and welfare.
Career Highlights
Kandace is currently employed at Boehringer Ingelheim Pharma GmbH & Co. KG, a leading global pharmaceutical company. Her work at this esteemed organization has allowed her to collaborate with other experts in the field and contribute to groundbreaking research in veterinary medicine.
Collaborations
One of her notable coworkers is Franz Birke, with whom she has likely shared insights and expertise in their joint efforts to advance veterinary medicine. Their collaboration exemplifies the importance of teamwork in driving innovation.
Conclusion
Kandace Matzek's contributions to veterinary medicine through her patent on LTB4 antagonists demonstrate her dedication to enhancing animal health. Her work at Boehringer Ingelheim Pharma GmbH & Co. KG continues to pave the way for future innovations in the field.